Radiant Biotherapeutics Secures $35M to Advance Therapeutic Platform for Life-threatening Diseases - Next Digital Health

Radiant Biotherapeutics, a Toronto-based pre-clinical biotechnology startup developing an advanced antibody platform to offer life-changing therapies for patients with life-threatening diseases, has secured $35 million in Series A funding round to fuel growth and advance its platform for clinics. Led by Arthur Fratamico and Jo Hulme, the company’s platform offers diverse biologics to help fight
read more..